Table 4.
|
Nasal isolates (n = 29) |
|||||||
---|---|---|---|---|---|---|---|---|
|
E. faecalis (n = 11) |
E. faecium (n = 18) |
||||||
Antibiotic dilutions | TET (%) | CIP (%) | OXA(%) | VAN (%) | TET (%) | CIP (%) | OXA (%) | VAN (%) |
0.5 |
---------- |
---------- |
---------- |
---------- |
---------- |
---------- |
---------- |
---------- |
1 |
†--------- |
1 (9.1) |
---------- |
5 (45.5) |
†--------- |
---------- |
---------- |
11 (61.1) |
2 |
2 (18.2) |
1 (9.1) |
†--------- |
3 (27.3) |
2 (11.1) |
2 (11.1) |
†--------- |
6 (33.3) |
4 |
2 (18.2) |
†--------- |
---------- |
1 (9.1) |
1 (5.6) |
†2 (11.1) |
1 (5.6) |
---------- |
8 |
1 (9.1) |
3 (27.3) |
1 (9.1) |
†--------- |
3 (16.7) |
2 (11.1) |
1 (5.6) |
†--------- |
16 |
---------- |
1 (9.1) |
1 (9.1) |
---------- |
1 (5.6) |
---------- |
1 (5.6) |
---------- |
32 |
---------- |
2 (18.2) |
2 (18.2) |
---------- |
---------- |
3 (16.7) |
1 (5.6) |
---------- |
64 |
---------- |
1 (9.1) |
2 (18.2) |
---------- |
1 (5.6) |
---------- |
1 (5.6) |
---------- |
128 |
3 (27.3) |
1 (9.1) |
2 (18.2) |
---------- |
6 (33.3) |
3 (16.7) |
3 (16.7) |
---------- |
256 |
3 (27.3) |
1 (9.1) |
1 (9.1) |
---------- |
4 (22.2) |
4 (22.2) |
6 (33.3) |
---------- |
512 |
---------- |
---------- |
2 (18.2) |
2 (18.2) |
---------- |
2 (11.1) |
4 (22.2) |
1 (5.6) |
t-test |
P < 0.05 |
P = 0.076 |
P < 0.05 |
P = 0.195 |
P < 0.05 |
P < 0.05 |
P < 0.05 |
P = 454 |
t = 3.182 | t = 1.981 | t = 2.772 | t = 1.389 | t = 4.488 | t = 3.499 | t = 5.239 | t = 0.766 |
† Breakpoint concentration, TET: Tetracycline, CIP: Ciprofloxacin, OXA: Oxacillin, VAN: Vancomycin.